Cited by 206Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 56 of the 60 references it cites were found in a registry or an index.

Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults

Open access

Karanth, Shama, Nelson, Peter T., Katsumata, Yuriko, Kryscio, Richard J., Schmitt, Frederick A., Fardo, David W., Cykowski, Matthew D., Jicha, Gregory A., Van Eldik, Linda J., Abner, Erin L.·2020·JAMA Neurology

DOI 10.1001/jamaneurol.2020.1741PMC PMC7309572

Open this paper in CoChat — free account Open PDF

Abstract

Importance: Quadruple misfolded proteins (tau neurofibrillary tangles, amyloid-β [Aβ], α-synuclein, and transactive response DNA-binding protein 43 [TDP-43]) in the same brain are relatively common in aging. However, the clinical presentation, associated factors, frequency in community-based cohorts, genetic characteristics, and cognitive trajectories associated with the quadruple misfolded proteins phenotype are not well understood. Objective: To describe the quadruple misfolded proteins phenotype, including the trajectories of global cognition, in an autopsy cohort. Design, Setting, and Participants: This retrospective cohort study used brain autopsy data from the University of Kentucky Alzheimer Disease Center (UK-ADC) Brain Bank. Participants were deceased individuals who were enrolled in a longitudinal community-based cohort study of aging and dementia in central Kentucky conducted by the UK-ADC. Included participants were enrolled in the UK-ADC cohort between January 1, 1989, and December 31, 2017; aged 55 years or older at baseline; and followed up for a mean duration of 10.4 years. The participants had Alzheimer disease pathology (tau and Aβ), α-synuclein, and TDP-43 data, along with Braak neurofibrillary tangle stage I to VI. Data analysis was conducted between February 1, 2019, and September 30, 2019. Main Outcomes and Measures: Frequency of quadruple misfolded proteins was estimated, and proteinopathy group characteristics and associations with global cognition were evaluated. Multinomial logistic regression was used to estimate the association of proteinopathy group with participant characteristics, including age at death, sex, and apolipoprotein ε4 (APOE ε4) allele. Generalized estimating equations were used to estimate the probability of obtaining Mini-Mental State Examination (MMSE) scores within the normal cognition (27-30 points) and severe impairment (≤13 points) ranges during the 12 years before death. Results: The final sample included 375 individuals (mean [SD] age at death, 86.9 [8.0] years); 232 women [61.9%]). Quadruple misfolded proteins were detected in 41 of 214 individuals with dementia (19.2%). Overall, 46 individuals (12.3%) had quadruple misfolded proteins, whereas 143 individuals (38.1%) had 3 proteinopathies. Dementia frequency was highest among those with quadruple misfolded proteins (41 [89.1%]), and participants with quadruple misfolded proteins had the lowest final mean (SD) MMSE scores of 13.4 (9.8) points. Adjusting for age at death and sex, the APOE ε4 allele was associated with higher odds of quadruple misfolded proteins (adjusted odds ratio, 2.55; 95% CI, 1.16- 5.62; P = .02). The quadruple misfolded proteins group had both the lowest probability of obtaining MMSE scores in the normal cognition range, even 12 years before death, and the highest probability of having MMSE scores in the severe impairment range. Conclusions and Relevance: Quadruple misfolded proteins appear to be a common substrate for cognitive impairment and to be associated with an aggressive course of disease that typically ends with severe dementia. The prevalence of comorbid α-synuclein and TDP-43 with Alzheimer disease pathology (tau and Aβ) may complicate efforts to identify therapies to treat and prevent Alzheimer disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jamaneurol.2020.1741

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Mild cognitive impairment – Beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment.
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894
Self-citation
Diagnostic and Statistical Manual of Mental Disorders
Raber, G., & Spokas, M. (2024) · doi:10.4135/9781071886229.n145 · Cited by 2,806
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050
Self-citation

Show all 60 references

Sorted by citations

Alzheimer disease
Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00269-y · Cited by 2,606
Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group
Dubois, B., Villain, N., Frisoni, G. B., Rabinovici, G. D., Sabbagh, M., Cappa, S., Bejanin, A., Bombois, S., Epelbaum, S., Teichmann, M., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00066-1 · Cited by 1,051
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
Ossenkoppele, R., Pichet Binette, A., Groot, C., Smith, R., Strandberg, O., Palmqvist, S., Stomrud, E., Tideman, P., Ohlsson, T., Jögi, J., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02049-x · Cited by 496
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised
Frisoni, G. B., Altomare, D., Thal, D. R., Ribaldi, F., van der Kant, R., Ossenkoppele, R., Blennow, K., Cummings, J., van Duijn, C., Nilsson, P. M., et al. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00533-w · Cited by 513
Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease
Spina, S., La Joie, R., Petersen, C., Nolan, A. L., Cuevas, D., Cosme, C., Hepker, M., Hwang, J.-H., Miller, Z. A., Huang, E. J., et al. (2021) · Brain · doi:10.1093/brain/awab099 · Cited by 278
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
Smirnov, D. S., Ashton, N. J., Blennow, K., Zetterberg, H., Simrén, J., Lantero‐Rodriguez, J., Karikari, T. K., Hiniker, A. O., Rissman, R. A., Salmon, D. P., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02408-5 · Cited by 231
Multifaceted roles of APOE in Alzheimer disease
Jackson, R. J., Hyman, B. T., & Serrano-Pozo, A. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00988-2 · Cited by 193
Is Alzheimer disease a disease?
Korczyn, A. D., & Grinberg, L. T. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00940-4 · Cited by 198
Heterogeneity in Alzheimer’s Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials
Duara, R., & Barker, W. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01185-z · Cited by 187
Air Pollution, Ultrafine Particles, and Your Brain: Are Combustion Nanoparticle Emissions and Engineered Nanoparticles Causing Preventable Fatal Neurodegenerative Diseases and Common Neuropsychiatric Outcomes?
Calderón‐Garcidueñas, L., & Ayala, A. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.1c04706 · Cited by 193
Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated
Robinson, J. L., Xie, S. X., Baer, D. R., Suh, E. R., Deerlin, V. M. V., Loh, N., Irwin, D. J., McMillan, C. T., Wolk, D. A., Chen‐Plotkin, A. S., et al. (2023) · Brain · doi:10.1093/brain/awad059 · Cited by 186
Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts
Nelson, P. T., Brayne, C., Flanagan, M. E., Abner, E. L., Agrawal, S., Attems, J., Castellani, R. J., Corrada, M. M., Cykowski, M. D., Di, J., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02444-1 · Cited by 187
Self-citation
New landscape of the diagnosis of Alzheimer’s disease
Frisoni, G. B., Hansson, O., Nichols, E., Garibotto, V., Schindler, S. E., van der Flier, W. M., Jessen, F., Villain, N., Arenaza-Urquijo, E. M., Crivelli, L., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01294-2 · Cited by 143
Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study
Florian, H., Wang, D., Arnold, S. E., Boada, M., Guo, Q., Jin, Z., Zheng, H., Fisseha, N., Kalluri, H. V., Rendenbach‐Mueller, B., et al. (2023) · Brain · doi:10.1093/brain/awad024 · Cited by 143
Alzheimer's disease outlook: controversies and future directions
Frisoni, G. B., Aho, E., Brayne, C., Ciccarelli, O., Dubois, B., Fox, N. C., Frederiksen, K. S., Gabay, C., Garibotto, V., Hofmarcher, T., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01389-3 · Cited by 116
Dysregulation of Systemic Immunity in Aging and Dementia
Lutshumba, J., Nikolajczyk, B. S., & Bachstetter, A. D. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.652111 · Cited by 104
Global and local ancestry modulate APOE association with Alzheimer’s neuropathology and cognitive outcomes in an admixed sample
Naslavsky, M. S., Suemoto, C. K., Brito, L. A., Scliar, M. O., Ferretti‐Rebustini, R. E. D. L., Rodriguez, R. D., Leite, R. E. P., Araujo, N. M., Borda, V., Tarazona‐Santos, E., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01729-x · Cited by 97
Current Concepts of Mixed Pathologies in Neurodegenerative Diseases
Forrest, S. L., & Kovács, G. G. (2022) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2022.34 · Cited by 104
Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease
Shim, K. H., Kang, M. J., Youn, Y. C., An, S. S. A., & Kim, S. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01150-0 · Cited by 106
Quadruple abnormal protein aggregates in brainstem pathology and exogenous metal-rich magnetic nanoparticles (and engineered Ti-rich nanorods). The substantia nigrae is a very early target in young urbanites and the gastrointestinal tract a key brainstem portal
Calderón‐Garcidueñas, L., González-Maciel, A., Reynoso-Robles, R., Hammond, J., Kulesza, R. J., Lachmann, I., Torres‐Jardón, R., Mukherjee, P. S., & Maher, B. A. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110139 · Cited by 98
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis
Chapleau, M., Joie, R. L., Yong, K. X. X., Agosta, F., Allen, I. E., Apostolova, L. G., Best, J., Boon, B. D. C., Crutch, S. J., Filippi, M., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00414-3 · Cited by 73
GWAS of multiple neuropathology endophenotypes identifies new risk loci and provides insights into the genetic risk of dementia
Shade, L. M. P., Katsumata, Y., Abner, E. L., Aung, K. Z., Claas, S. A., Qiao, Q., Heberle, B. A., Brandon, J. A., Page, M. L., Hohman, T. J., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01939-9 · Cited by 72
Self-citation
A Neurotoxic Ménage-à-trois: Glutamate, Calcium, and Zinc in the Excitotoxic Cascade
Granzotto, A., Canzoniero, L. M. T., & Sensi, S. L. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.600089 · Cited by 67
When Alzheimer's is LATE : Why Does it Matter?
Nelson, P. T., Schneider, J. A., Jicha, G. A., Duong, M. T., & Wolk, D. A. (2023) · Annals of Neurology · doi:10.1002/ana.26711 · Cited by 68
Self-citation
TDP-43 pathology is associated with increased tau burdens and seeding
Tomé, S. O., Tsaka, G., Ronisz, A., Ospitalieri, S., Gawor, K., Gomes, L. A., Otto, M., Arnim, C. A. F. V., Damme, P. V., Bosch, L. V. D., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00653-0 · Cited by 74
Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease
Ossenkoppele, R., & Hansson, O. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12356 · Cited by 62
Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease
Uemura, M. T., Robinson, J. L., Cousins, K. A. Q., Tropea, T. F., Kargilis, D., McBride, J. D., Suh, E. R., Xie, S. X., Xu, Y., Porta, S., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02383-3 · Cited by 59
Advances in Deep Neuropathological Phenotyping of Alzheimer Disease: Past, Present, and Future
Shakir, M., & Dugger, B. N. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab122 · Cited by 58
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex
Ossenkoppele, R., Coomans, E. M., Apostolova, L. G., Baker, S. L., Barthel, H., Beach, T. G., Benzinger, T. L. S., Betthauser, T. J., Bischof, G. N., Bottlaender, M., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02000-6 · Cited by 60
Repetitive head impacts and chronic traumatic encephalopathy are associated with TDP-43 inclusions and hippocampal sclerosis
Nicks, R., Clement, N. F., Alvarez, V. E., Tripodis, Y., Baucom, Z. H., Huber, B. R., Mez, J., Alosco, M. L., Aytan, N., Cherry, J. D., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02539-3 · Cited by 54
Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders
Akanji, M. A., Rotimi, D. E., Elebiyo, T. C., Awakan, O. J., & Adeyemı, O. S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9971885 · Cited by 55
Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK‐ADRC cohort
Foley, K. E., Winder, Z., Sudduth, T. L., Martin, B. J., Nelson, P. T., Jicha, G. A., Harp, J. P., Weekman, E. M., & Wilcock, D. M. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13485 · Cited by 55
Self-citation
Estrogen, menopause, and Alzheimer’s disease: understanding the link to cognitive decline in women
Mervosh, N. L., & Devi, G. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1634302 · Cited by 62
Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): Co-pathologies and genetic risk factors provide clues about pathogenesis
Nelson, P. T., Fardo, D. W., Wu, X., Aung, K. Z., Cykowski, M. D., & Katsumata, Y. (2024) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlae032 · Cited by 54
Self-citation
The impact of demographic, clinical, genetic, and imaging variables on tau PET status
Ossenkoppele, R., Leuzy, A., Cho, H., Sudre, C. H., Strandberg, O. T., Smith, R. A., Palmqvist, S., Mattsson, N., Olsson, T., Jögi, J., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05099-w · Cited by 53
Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy
Katsumata, Y., Abner, E. L., Karanth, S. D., Teylan, M., Mock, C., Cykowski, M. D., Lee, E. B., Boehme, K. L., Mukherjee, S., Kauwe, J. S. K., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02211-0 · Cited by 48
Self-citation
A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease
Turk, K. W., Geada, A., Alvarez, V. E., Xia, W., Cherry, J. D., Nicks, R., Meng, G., Daley, S. A., Tripodis, Y., Huber, B. R., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00976-y · Cited by 47
Alzheimer and Parkinson diseases, frontotemporal lobar degeneration and amyotrophic lateral sclerosis overlapping neuropathology start in the first two decades of life in pollution exposed urbanites and brain ultrafine particulate matter and industrial nanoparticles, including Fe, Ti, Al, V, Ni, Hg, Co, Cu, Zn, Ag, Pt, Ce, La, Pr and W are key players. Metropolitan Mexico City health crisis is in progress
Calderón‐Garcidueñas, L., Stommel, E. W., Torres‐Jardón, R., Hernández-Luna, J., Aiello-Mora, M., González-Maciel, A., Reynoso-Robles, R., Pérez-Guillé, B., Silva-Pereyra, H. G., Tehuacanero-Cuapa, S., et al. (2024) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1297467 · Cited by 49
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease
Barba, L., Abu‐Rumeileh, S., Barthel, H., Massa, F., Foschi, M., Bellomo, G., Gaetani, L., Thal, D. R., Parnetti, L., & Otto, M. (2024) · Brain · doi:10.1093/brain/awae203 · Cited by 52
Neurodegenerative pathologies associated with behavioral and psychological symptoms of dementia in a community-based autopsy cohort
Nelson, R. S., Abner, E. L., Jicha, G. A., Schmitt, F. A., Di, J., Wilcock, D. M., Barber, J. M., Eldik, L. J. V., Katsumata, Y., Fardo, D. W., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01576-z · Cited by 44
Self-citation
The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer’s dementia in older persons
Agrawal, S., Yu, L., Nag, S., Arfanakis, K., Barnes, L. L., Bennett, D. A., & Schneider, J. A. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01260-0 · Cited by 48
Implications of the Approval of Lecanemab for Alzheimer Disease Patient Care
Knopman, D. S., & Hershey, L. A. (2023) · Neurology · doi:10.1212/wnl.0000000000207438 · Cited by 47
Annexin A11 aggregation in FTLD–TDP type C and related neurodegenerative disease proteinopathies
Robinson, J. L., Suh, E. R., Xu, Y., Hurtig, H. I., Elman, L. B., McMillan, C. T., Irwin, D. J., Porta, S., Deerlin, V. M. V., & Lee, E. B. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02753-7 · Cited by 45
Current concepts and molecular pathology of neurodegenerative diseases
Forrest, S. L., & Kovács, G. G. (2024) · Pathology · doi:10.1016/j.pathol.2024.10.006 · Cited by 44
Unbiased classification of the elderly human brain proteome resolves distinct clinical and pathophysiological subtypes of cognitive impairment
Higginbotham, L. A., Carter, E. K., Dammer, E. B., Haque, R. U., Johnson, E. C. B., Duong, D. M., Yin, L., Jager, P. L. D., Bennett, D. A., Felsky, D., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106286 · Cited by 41
Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer’s-type neuropathology
Karanth, S. D., Katsumata, Y., Nelson, P. T., Fardo, D. W., McDowell, J. K., Schmitt, F. A., Kryscio, R. J., Browning, S. R., Braithwaite, D., Arnold, S. M., et al. (2022) · Brain · doi:10.1093/brain/awac035 · Cited by 38
Self-citation
Inflammatory Biomarkers Aid in Diagnosis of Dementia
Erhardt, E. B., Adair, J. C., Knoefel, J. E., Caprihan, A., Prestopnik, J., Thompson, J., Hobson, S., Siegel, D., & Rosenberg, G. A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.717344 · Cited by 42
Clinical criteria for a limbic-predominant amnestic neurodegenerative syndrome
Corriveau‐Lecavalier, N., Botha, H., Graff‐Radford, J., Switzer, A. R., Przybelski, S. A., Wiste, H. J., Murray, M. E., Reichard, R. R., Dickson, D. W., Nguyen, A. T., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae183 · Cited by 47
Self-citation
Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)
Sturchio, A., Marsili, L., Vizcarra, J. A., Dwivedi, A. K., Kauffman, M., Duker, A. P., Lu, P., Pauciulo, M. W., Wissel, B. D., Hill, E. J., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.553635 · Cited by 39
Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies
Maldonado‐Díaz, C., Hiya, S., Yokoda, R. T., Farrell, K. W., Marx, G. A., Kauffman, J., Daoud, E. V., Gonzales, M. M., Parker, A. S., Canbeldek, L., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02716-y · Cited by 38
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers
Gibson, L. L., Ruiz, C. A., Chong, J. R., Ballard, C. G., & Aarsland, D. (2023) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001173 · Cited by 36
ADNI Biomarker Core: A review of progress since 2004 and future challenges
Shaw, L. M. J., Korecka, M., Lee, E. B., Cousins, K. A. Q., Vanderstichele, H., Schindler, S. E., Tosun, D., DeMarco, M. L., Brylska, M., Wan, Y., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14264 · Cited by 38
Association of glial tau pathology and LATE-NC in the ageing brain
Forrest, S. L., Wagner, S., Kim, A., & Kovács, G. G. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.07.010 · Cited by 35
Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson’s disease: current evidence and future perspectives
Mantovani, E., Zucchella, C., Argyriou, A. A., & Tamburin, S. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2173576 · Cited by 35
The relationship between hippocampal amyloid beta burden and spatial distribution of neurofibrillary degeneration
Walker, J. M., Goette, W. F., Farrell, K. W., Iida, M. A., Karlovich, E., The PART Working Group, White, C. L., Crary, J. F., & Richardson, T. E. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12966 · Cited by 35
Environmentally Toxic Solid Nanoparticles in Noradrenergic and Dopaminergic Nuclei and Cerebellum of Metropolitan Mexico City Children and Young Adults with Neural Quadruple Misfolded Protein Pathologies and High Exposures to Nano Particulate Matter
Calderón‐Garcidueñas, L., González-Maciel, A., Reynoso-Robles, R., Silva-Pereyra, H. G., Torres‐Jardón, R., Brito-Aguilar, R., Ayala, A., Stommel, E. W., & Delgado‐Chávez, R. (2022) · Toxics · doi:10.3390/toxics10040164 · Cited by 34
Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD
Afroz, T., Chevalier, E., Audrain, M., Dumayne, C., Ziehm, T., Moser, R., Egesipe, A.-L., Mottier, L., Ratnam, M., Neumann, M., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106050 · Cited by 35
Self-citation
The Interplay of Inflammation and Gut-Microbiota Dysbiosis in Alzheimer’s Disease: Mechanisms and Therapeutic Potential
Samat, H. N. A., Razali, N. N., Mahadzir, H., Muhammad, T. S. T., Ling, K., Mansor, N. I., & Abidin, S. Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188905 · Cited by 34
Symptomatic Profile and Cognitive Performance in Autopsy-Confirmed Limbic-Predominant Age-Related TDP-43 Encephalopathy With Comorbid Alzheimer Disease
Gauthreaux, K. M., Mock, C., Teylan, M., Culhane, J. E., Chen, Y., Chan, K. C. G., Katsumata, Y., Nelson, P. T., & Kukull, W. A. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac093 · Cited by 29
Self-citation
APOE Peripheral and Brain Impact: APOE4 Carriers Accelerate Their Alzheimer Continuum and Have a High Risk of Suicide in PM2.5 Polluted Cities
Calderón‐Garcidueñas, L., Hernández-Luna, J., Aiello-Mora, M., Brito-Aguilar, R., Evelson, P., Villarreal-Ríos, R., Torres‐Jardón, R., Ayala, A., & Mukherjee, P. S. (2023) · Biomolecules · doi:10.3390/biom13060927 · Cited by 28
Limbic-predominant age-related TDP-43 encephalopathy in the oldest old: a population-based study
Mikhailenko, E., Colangelo, K., Tuimala, J., Kero, M., Savola, S. E., Raunio, A., Kok, E., Tanskanen, M., Mäkelä, M., Puttonen, H. A. J., et al. (2024) · Brain · doi:10.1093/brain/awae212 · Cited by 30
Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases
de Ruyter, F. J. H., Evers, M. J. A. P., Morrema, T. H. J., Dijkstra, A. A., den Haan, J., Twisk, J. W. R., de Boer, J. F., Scheltens, P., Bouwman, F. H., Verbraak, F. D., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02769-z · Cited by 27
A how-to guide for a precision medicine approach to the diagnosis and treatment of Alzheimer's disease
Devi, G. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1213968 · Cited by 29
Genetic and Environmental Factors Influence the Pleomorphy of LRRK2 Parkinsonism
Chittoor-Vinod, V. G., Nichols, R. J., & Schüle, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031045 · Cited by 26
CSF Biomarkers of Alzheimer Disease in Patients With Concomitant α-Synuclein Pathology
Cousins, K. A. Q., Arezoumandan, S., Shellikeri, S., Ohm, D., Shaw, L. M., Grossman, M., Wolk, D., McMillan, C. T., Chen-Plotkin, A., Lee, E., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000201202 · Cited by 25
Role of tau versus TDP‐43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease
Wisse, L. E. M., Wuestefeld, A., Murray, M. E., Jagust, W. J., & Joie, R. L. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14582 · Cited by 24
Cognitive resistance to and resilience against multiple comorbid neurodegenerative pathologies and the impact of APOE status
Walker, J. M., & Richardson, T. E. (2023) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac115 · Cited by 26
Terminally differentiated effector memory T cells associate with cognitive and AD-related biomarkers in an aging-based community cohort
Winford, E. D., Lutshumba, J., Martin, B. J., Wilcock, D. M., Jicha, G. A., Nikolajczyk, B. S., Stowe, A. M., & Bachstetter, A. D. (2024) · Immunity & Ageing · doi:10.1186/s12979-024-00443-2 · Cited by 27
Self-citation
Biomarkers for cognitive impairment in alpha-synucleinopathies: an overview of systematic reviews and meta-analyses
Mantovani, E., Martini, A., Dinoto, A., Zucchella, C., Ferrari, S., Mariotto, S., Tinazzi, M., & Tamburin, S. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00823-x · Cited by 29
Neuropathological associations of limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) differ between the oldest-old and younger-old
Wang, S. J., Guo, Y., Ervin, J. F., Lusk, J. B., & Luo, S. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02432-5 · Cited by 28
Sleep matters: Neurodegeneration spectrum heterogeneity, combustion and friction ultrafine particles, industrial nanoparticle pollution, and sleep disorders—Denial is not an option
Calderón‐Garcidueñas, L., Torres‐Jardón, R., Greenough, G. P., Kulesza, R. J., González-Maciel, A., Reynoso-Robles, R., García-Alonso, G., Chávez-Franco, D. A., García-Rojas, E., Brito-Aguilar, R., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1117695 · Cited by 25
The tauopathies
Devi, G. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98817-9.00015-6 · Cited by 27
Four Common Late-Life Cognitive Trajectories Patterns Associate with Replicable Underlying Neuropathologies
Karanth, S. D., Schmitt, F. A., Nelson, P. T., Katsumata, Y., Kryscio, R. J., Fardo, D. W., Harp, J. P., & Abner, E. L. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210293 · Cited by 22
Self-citation
Distinct neurotoxic TDP-43 fibril polymorphs are generated by heterotypic interactions with α-Synuclein
Dhakal, S., Robang, A. S., Bhatt, N. N., Puangmalai, N., Fung, L., Kayed, R., Paravastu, A. K., & Rangachari, V. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102498 · Cited by 23
TDP-43 CSF Concentrations Increase Exponentially with Age in Metropolitan Mexico City Young Urbanites Highly Exposed to PM2.5 and Ultrafine Particles and Historically Showing Alzheimer and Parkinson’s Hallmarks. Brain TDP-43 Pathology in MMC Residents Is Associated with High Cisternal CSF TDP-43 Concentrations
Calderón‐Garcidueñas, L., Stommel, E. W., Lachmann, I., Waniek, K., Chao, C., González-Maciel, A., García-Rojas, E., Torres‐Jardón, R., Delgado‐Chávez, R., & Mukherjee, P. S. (2022) · Toxics · doi:10.3390/toxics10100559 · Cited by 22
Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer’s Coordinating Center database
Woodworth, D. C., Nguyen, K. M., Sordo, L., Scambray, K. A., Head, E., Kawas, C. H., Corrada, M. M., Nelson, P. T., & Sajjadi, S. A. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02728-8 · Cited by 27
Self-citation
Differences in Symptomatic Presentation and Cognitive Performance Among Participants With LATE-NC Compared to FTLD-TDP
Teylan, M., Mock, C., Gauthreaux, K. M., Culhane, J. E., Jicha, G. A., Chen, Y., Chan, K. C. G., Kukull, W. A., Nelson, P. T., & Katsumata, Y. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab098 · Cited by 22
Self-citation
Posterior cingulate cortex reveals an expression profile of resilience in cognitively intact elders
Kelley, C. M., Ginsberg, S. D., Liang, W. S., Counts, S., & Mufson, E. J. (2022) · Brain Communications · doi:10.1093/braincomms/fcac162 · Cited by 23
Use of Artificial Intelligence in Imaging Dementia
Aljuhani, M., Ashraf, A., & Edison, P. (2024) · Cells · doi:10.3390/cells13231965 · Cited by 21
Cognitive symptoms progress with limbic-predominant age-related TDP-43 encephalopathy stage and co-occurrence with Alzheimer disease
Hiya, S., Maldonado‐Díaz, C., Walker, J. M., & Richardson, T. E. (2023) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlad098 · Cited by 24
Association between WWOX/MAF variants and dementia-related neuropathologic endophenotypes
Dugan, A. J., Nelson, P. T., Katsumata, Y., Shade, L. M. P., Teylan, M., Boehme, K. L., Mukherjee, S., Kauwe, J. S. K., Hohman, T. J., Schneider, J. A., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.10.011 · Cited by 18
Self-citation
Conserved age‐related increases in hippocampal PDE11A4 cause unexpected proteinopathies and cognitive decline of social associative memories
Pilarzyk, K., Porcher, L., Capell, W. R., Burbano, S. D., Davis, J., Fisher, J. L., Gorny, N., Petrolle, S., & Kelly, M. P. (2022) · Aging Cell · doi:10.1111/acel.13687 · Cited by 17
LATE‐NC in Alzheimer's disease: Molecular aspects and synergies
Tomé, S. O., Gawor, K., & Thal, D. R. (2023) · Brain Pathology · doi:10.1111/bpa.13213 · Cited by 21
Amyloid‐β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects
Yu, Y., Yu, S., Battaglia, G., & Tian, X. (2024) · Ibrain · doi:10.1002/ibra.12155 · Cited by 19
Scenarios for the long‐term efficacy of amyloid‐targeting therapies in the context of the natural history of Alzheimer's disease
Rakêt, L. L., Cummings, J. L., Moscoso, A., Villain, N., & Schöll, M. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14134 · Cited by 18
Apolipoprotein E Proteinopathy Is a Major Dementia-Associated Pathologic Biomarker in Individuals with or without the APOE Epsilon 4 Allele
Gal, J., Katsumata, Y., Zhu, H., Srinivasan, S., Chen, J., Johnson, L. A., Wang, W.-X., Golden, L. R., Wilcock, D. M., Jicha, G. A., et al. (2022) · The American Journal of Pathology · doi:10.1016/j.ajpath.2021.11.013 · Cited by 17
Self-citation
Cognitive and Neuropsychological Profiles in Alzheimer’s Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies
Walker, J. M., Gonzales, M. M., Goette, W. F., Farrell, K. W., White, C. L., Crary, J. F., & Richardson, T. E. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230022 · Cited by 18
Alzheimer's disease and its co‐pathologies: Implications for hippocampal degeneration, cognitive decline, and the role of APOE ε4
Gawor, K., Verrept, S., Arekatla, G., Wouters, D., Ronisz, A., Hecht, M., Laureyssen, C., Donck, H. V., Lahaije, B., Ospitalieri, S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70483 · Cited by 18
Cognitive and neuropsychological trajectories in patients with mixed neurodegenerative pathologies
Almeida, F., Marx, G. A., Rohde, S. K., Gonzales, M. M., Maldonado‐Díaz, C., Hiya, S., Clare, K. M., Samanamud, J. L., Slocum, C., Kauffman, J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70575 · Cited by 15
Brainstem Quadruple Aberrant Hyperphosphorylated Tau, Beta-Amyloid, Alpha-Synuclein and TDP-43 Pathology, Stress and Sleep Behavior Disorders
Calderón‐Garcidueñas, L., Rajkumar, R. P., Stommel, E. W., Kulesza, R. J., Mansour, Y., Villanueva, A. R., Flores-Vázquez, J. O., Brito-Aguilar, R., Ramírez-Sánchez, S., García-Alonso, G., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18136689 · Cited by 16
Fall Risk, Sleep Behavior, and Sleep-Related Movement Disorders in Young Urbanites Exposed to Air Pollution
Calderón‐Garcidueñas, L., Kulesza, R. J., Greenough, G. P., García-Rojas, E., Revueltas-Ficachi, P., Villanueva, A. R., Flores-Vázquez, J. O., Brito-Aguilar, R., Ramírez-Sánchez, S., Vacaseydel-Aceves, N., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220850 · Cited by 16
Recalibrating the Why and Whom of Animal Models in Parkinson Disease: A Clinician’s Perspective
Sturchio, A., Rocha, E. M., Kauffman, M., Marsili, L., Mahajan, A., Saraf, A., Vizcarra, J. A., Guo, Z., & Espay, A. J. (2024) · Brain Sciences · doi:10.3390/brainsci14020151 · Cited by 18
Common neuropathologic change drivers of hippocampal sclerosis of ageing
Woodworth, D. C., Lou, J., Yong, W. H., Head, E., Corrada, M. M., Nelson, P. T., & Sajjadi, S. A. (2025) · Brain · doi:10.1093/brain/awaf158 · Cited by 16
Self-citation
A review of the current research on in vivo and in vitro detection for alpha-synuclein: a biomarker of Parkinson’s disease
Wang, R., Pang, S., Li, J., Li, C.-L., Liu, J.-M., Wang, Y., Chen, M., & Li, Y. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-04520-1 · Cited by 16
The Association Between Neurocognitive Disorders and Gustatory Dysfunction: A Systematic Review and Meta-Analysis
Mantovani, E., Zanini, A., Cecchini, M. P., & Tamburin, S. (2023) · Neuropsychology Review · doi:10.1007/s11065-023-09578-3 · Cited by 15
Pure LATE-NC: Frequency, clinical impact, and the importance of considering APOE genotype when assessing this and other subtypes of non-Alzheimer’s pathologies
Katsumata, Y., Wu, X., Aung, K. Z., Fardo, D. W., Woodworth, D. C., Sajjadi, S. A., Tomé, S. O., Thal, D. R., Troncoso, J. C., Chang, K., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02821-y · Cited by 14
Self-citation
The unique neuropathological vulnerability of the human brain to aging
Ferrer, I. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101916 · Cited by 15
Single-domain magnetic particles with motion behavior under electromagnetic AC and DC fields are a fatal cargo in Metropolitan Mexico City pediatric and young adult early Alzheimer, Parkinson, frontotemporal lobar degeneration and amyotrophic lateral sclerosis and in ALS patients
Calderón‐Garcidueñas, L., Cejudo, R., Stommel, E. W., González-Maciel, A., Reynoso-Robles, R., Torres‐Jardón, R., Tehuacanero-Cuapa, S., Rodríguez‐Gómez, A., Bautista, F., Goguitchaichvili, A., et al. (2024) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2024.1411849 · Cited by 13
Perivascular phosphorylated TDP ‐43 inclusions are associated with Alzheimer's disease pathology and loss of CD146 and Aquaporin‐4
Santiago, J., Pocevičiūtė, D., Bank, T. N. B., & Wennström, M. (2024) · Brain Pathology · doi:10.1111/bpa.13304 · Cited by 14
Use of anti-amyloid therapies for Alzheimer’s disease in Brazil: a position paper from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology
Barbosa, B. J. A. P., Resende, E. D. P. F., Castilhos, R. M., Borelli, W. V., Frota, N. A. F., Balthazar, M. L. F., Filho, A. C. S. A., Smid, J., Barbosa, M. T., Coutinho, A. M., et al. (2024) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2024-c002 · Cited by 17

Authors: Karanth, S., Nelson, P. T., Katsumata, Y., Kryscio, R. J., Schmitt, F. A., Fardo, D. W., Cykowski, M. D., Jicha, G. A., Van Eldik, L. J., & Abner, E. L.
Affiliations: University of Kentucky (US)
Houston Methodist (US)
Sanders-Brown Center on Aging, University of Kentucky, Lexington
Corresponding author: Abner, Erin L.
ORCID: Karanth, Shama
Nelson, Peter T.
Katsumata, Yuriko
Kryscio, Richard J.
Schmitt, Frederick A.
Fardo, David W.
Cykowski, Matthew D.
Jicha, Gregory A.
Abner, Erin L.
Venue: JAMA Neurology
Publisher: American Medical Association (AMA)
Published: 2020-10-01
Volume: 77
Issue: 10
Pages: 1299
ISSN: 2168-6149 (ISSN-L)
DOI: 10.1001/jamaneurol.2020.1741
PMC: PMC7309572
OpenAlex: W3035869254
Cited by: 206
References: 60
Citations by year: 2026: 25 · 2025: 33 · 2024: 46 · 2023: 33 · 2022: 38 · 2021: 24 · 2020: 7
FWCI: 18.61
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: JAMA Neurology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Eli Lilly and Company
Eisai
National Institutes of Health (5r01ag038651-10)
National Institute on Aging (AG-028383, R01‐AG038651, P30AG028383, P01AG003949, R56AG057191, P30AG072946)
National Heart, Lung, and Blood Institute
National Institute on Drug Abuse
National Institute of Child Health and Human Development
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: neurofibrillary tangles, amyloid-beta, alpha-synuclein, TDP-43, proteinopathies, dementia, Alzheimer's disease, cognitive trajectories, APOE ε4, older adults, autopsy brain tissue, clinical phenotype, central Kentucky
MeSH terms: Aged, Aged, 80 and over, DNA-Binding Proteins, Female, Follow-Up Studies, Humans, Male, Phenotype, Retrospective Studies, Cohort Studies, Prevalence, Amyloid beta-Peptides, Neurofibrillary Tangles, tau Proteins, alpha-Synuclein, Proteostasis Deficiencies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks